Showing results (1-10 of 432) with videos related to

Sort By:
Pageof 44
Der Internist|March 5, 2013
[Hypereosinophilic syndrome]F Moosig, G Richardt, C Merten, et al.
Zeitschrift Fur Rheumatologie|May 5, 2012
[Esophagitis during immunosuppression]F Moosig, W L Gross
Zeitschrift Fur Rheumatologie|March 24, 2010
[The significance of health-related quality of life in systemic vasculitides]K Herlyn, F Moosig, W L Gross
Der Internist|April 23, 2011
[Therapy of vasculitides: according to recommendations of the European League Against Rheumatism (EULAR) and European Vasculitis Study Group (EUVAS)]J U Holle, F Moosig, W L Gross, et al.
Der Internist|February 10, 2009
[Autoimmune vasculitides. Standards and guidelines of EULAR and EUVAS]F Moosig, J U Holle, W L Gross, et al.
Clinical and Experimental Immunology|October 9, 1998
Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cellsF Moosig, E Csernok, G Wang, et al.
Der Radiologe|March 31, 2009
[Large-vessel vasculitis. Imaging and interventional therapy]M Both, F Moosig, W L Gross, et al.
Clinical and Experimental Immunology|December 21, 2000
Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha)F Moosig, E Csernok, G Kumanovics, et al.
Clinical and Experimental Rheumatology|July 15, 2000
Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitisP Lamprecht, F Moosig, A Gause, et al.
The Journal of Rheumatology|August 26, 1998
Elevated procalcitonin levels in active Wegener's granulomatosisF Moosig, E Csernok, E Reinhold-Keller, et al.
Pageof 44